nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Anticholinergic Drug Use and Mortality Among Residents of Long-Term Care Facilities: A Prospective Cohort Study
|
Kumpula, Eeva-Katri |
|
2011 |
51 |
2 |
p. 256-263 |
artikel |
2 |
Assessment of the Effects of Renal Impairment on the Pharmacokinetic Profile of Laninamivir, a Novel Neuraminidase Inhibitor, After a Single Inhaled Dose of Its Prodrug, CS-8958
|
Ishizuka, Hitoshi |
|
2011 |
51 |
2 |
p. 243-251 |
artikel |
3 |
CYP3AP1*3 Allele Is Associated With Lipid-Lowering Efficacy of Simvastatin and Atorvastatin in Chinese Women
|
Li, Yan-Peng |
|
2011 |
51 |
2 |
p. 181-188 |
artikel |
4 |
Database Evaluation of the Effects of Long-Term Rosiglitazone Treatment on Cardiovascular Outcomes in Patients With Type 2 Diabetes
|
Loebstein, Ronen |
|
2011 |
51 |
2 |
p. 173-180 |
artikel |
5 |
De Novo Dose-Dependent Catatonia Due to Disulfiram Therapy: A Report and Review
|
Saddichha, Sahoo |
|
2011 |
51 |
2 |
p. 285-286 |
artikel |
6 |
Distribution of Bupivacaine Enantiomers and Lidocaine and Its Metabolite in the Placental Intervillous Space and in the Different Maternal and Fetal Compartments in Term Pregnant Women
|
de Barros Duarte, Luciana |
|
2011 |
51 |
2 |
p. 212-217 |
artikel |
7 |
Effect of Administration Time of Exenatide on Satiety Responses, Blood Glucose, and Adverse Events in Healthy Volunteers
|
Pinelli, Nicole R. |
|
2011 |
51 |
2 |
p. 165-172 |
artikel |
8 |
Effect of Verapamil on the Pharmacokinetics of Aliskiren in Healthy Participants
|
Rebello, Sam |
|
2011 |
51 |
2 |
p. 218-228 |
artikel |
9 |
Metabolism and Excretion of [14C] Febuxostat, a Novel Nonpurine Selective Inhibitor of Xanthine Oxidase, in Healthy Male Subjects
|
Grabowski, Brian A. |
|
2011 |
51 |
2 |
p. 189-201 |
artikel |
10 |
Modeling of 24-Hour Glucose and Insulin Profiles of Patients With Type 2 Diabetes
|
Jauslin, Petra M. |
|
2011 |
51 |
2 |
p. 153-164 |
artikel |
11 |
Patterns of Antidepressant Medication Use Among Pregnant Women in a United States Population
|
Alwan, Sura |
|
2011 |
51 |
2 |
p. 264-270 |
artikel |
12 |
Pharmacokinetic Interactions Between Darunavir/Ritonavir and Opioid Maintenance Therapy Using Methadone or Buprenorphine/ Naloxone
|
Sekar, Vanitha |
|
2011 |
51 |
2 |
p. 271-278 |
artikel |
13 |
Review: Novel Avenues of Drug Discovery and Biomarkers for Diabetes Mellitus
|
Maiese, Kenneth |
|
2011 |
51 |
2 |
p. 128-152 |
artikel |
14 |
Safety and Pharmacokinetics of Higher Doses of Caspofungin in Healthy Adult Participants
|
Migoya, Elizabeth M. |
|
2011 |
51 |
2 |
p. 202-211 |
artikel |
15 |
Serum Transaminase Levels Should Be Measured Immediately Prior to Dosing in Early Phase I Clinical Trials
|
Groen, David |
|
2011 |
51 |
2 |
p. 252-255 |
artikel |
16 |
The Effect of Lopinavir/Ritonavir and Darunavir/Ritonavir on the HIV Integrase Inhibitor S/GSK1349572 in Healthy Participants
|
Song, Ivy |
|
2011 |
51 |
2 |
p. 237-242 |
artikel |
17 |
Unexpected Effect of Rifampin on the Pharmacokinetics of Linezolid: In Silico and In Vitro Approaches to Explain Its Mechanism
|
Gandelman, Kuan |
|
2011 |
51 |
2 |
p. 229-236 |
artikel |
18 |
Using Routinely Collected Prescribing Data to Determine Drug Persistence for the Purpose of Pharmacovigilance
|
Mohamed, Isa Naina |
|
2011 |
51 |
2 |
p. 279-284 |
artikel |